Biểu đồ giá cổ phiếu IVA
IVA Dự đoán giá cổ phiếu
Inventiva S.A.
$5.35
-0.92%
$-0.05
Khi đóng cửa: May 07, 16:00:00 GMT-4
$5.35
0%
$0
Phiên sau giờ: May 07, 20:00:00 GMT-4
Quay lại
Inventiva S.A. (IVA) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$5.4
Giá mở cửa
$5.44
Phạm vi ngày
$5.28 - $5.52
Phạm vi 52 tuần
$2.85 - $7.98
Khối lượng
374.0K
Khối lượng trung bình
363.1K
Tỷ suất cổ tức
--
EPS (TTM)
-2.23
Vốn hóa thị trường
$1.1B
Inventiva S.A. - American Depos là gì?
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. The company employs 58 full-time employees The company went IPO on 2017-02-15. The firm focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.
